Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPEGINTERFERON ALFA-2B: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

90.0%
Female
10.0%
Male

Age Information

The average age of patients reporting adverse events with ROPEGINTERFERON ALFA-2B is 60.6 years.

Geographic Distribution

The majority of adverse event reports for ROPEGINTERFERON ALFA-2B originate from US.

Report Summary & Outcomes

13
Total Reports
13
As Primary/Secondary Suspect
1
Deaths Reported
4
Hospitalizations
2
Life-Threatening

Reporting Timeline

First adverse event report: 20220224. Most recent report: 20241227. View full timeline →

More About ROPEGINTERFERON ALFA-2B

ROPEGINTERFERON ALFA-2B Full Profile Reports by Year Drug Interactions